These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20656008)

  • 21. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
    García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
    Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug- and toxin-induced hepatotoxicity].
    Grünhage F; Fischer HP; Sauerbruch T; Reichel C
    Z Gastroenterol; 2003 Jun; 41(6):565-78. PubMed ID: 12806543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A special issue about hepatotoxicity and hepatocyte in vitro systems.
    Ilkavets I
    Arch Toxicol; 2013 Aug; 87(8):1313-4. PubMed ID: 23864025
    [No Abstract]   [Full Text] [Related]  

  • 24. Computational chemistry approach for the early detection of drug-induced idiosyncratic liver toxicity.
    Cruz-Monteagudo M; Cordeiro MN; Borges F
    J Comput Chem; 2008 Mar; 29(4):533-49. PubMed ID: 17705164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity.
    Meng Q
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):733-46. PubMed ID: 20380484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of organ toxicity endpoints by QSAR modeling based on precise chemical-histopathology annotations.
    Myshkin E; Brennan R; Khasanova T; Sitnik T; Serebriyskaya T; Litvinova E; Guryanov A; Nikolsky Y; Nikolskaya T; Bureeva S
    Chem Biol Drug Des; 2012 Sep; 80(3):406-16. PubMed ID: 22583392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capture compound mass spectrometry sheds light on the molecular mechanisms of liver toxicity of two Parkinson drugs.
    Fischer JJ; Michaelis S; Schrey AK; Graebner OG; Glinski M; Dreger M; Kroll F; Koester H
    Toxicol Sci; 2010 Jan; 113(1):243-53. PubMed ID: 19783845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highlight report: towards the replacement of in vivo repeated dose systemic toxicity testing.
    Hengstler JG; Marchan R; Leist M
    Arch Toxicol; 2012 Jan; 86(1):13-5. PubMed ID: 22187068
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes.
    Wang T; Shankar K; Ronis MJ; Mehendale HM
    Crit Rev Toxicol; 2007 Jun; 37(5):413-59. PubMed ID: 17612954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-content analysis/screening for predictive toxicology: application to hepatotoxicity and genotoxicity.
    Persson M; Løye AF; Jacquet M; Mow NS; Thougaard AV; Mow T; Hornberg JJ
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):18-23. PubMed ID: 24461077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope.
    Mulliner D; Schmidt F; Stolte M; Spirkl HP; Czich A; Amberg A
    Chem Res Toxicol; 2016 May; 29(5):757-67. PubMed ID: 26914516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation.
    Zhang X; Jiang T; Chen D; Wang Q; Zhang LW
    Crit Rev Toxicol; 2020 Apr; 50(4):279-309. PubMed ID: 32419588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Silico Modeling for the Prediction of Dose and Pathway-Related Adverse Effects in Humans From In Vitro Repeated-Dose Studies.
    Klein S; Maggioni S; Bucher J; Mueller D; Niklas J; Shevchenko V; Mauch K; Heinzle E; Noor F
    Toxicol Sci; 2016 Jan; 149(1):55-66. PubMed ID: 26420750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The liver toxicity knowledge base: a systems approach to a complex end point.
    Chen M; Zhang J; Wang Y; Liu Z; Kelly R; Zhou G; Fang H; Borlak J; Tong W
    Clin Pharmacol Ther; 2013 May; 93(5):409-12. PubMed ID: 23486446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancing Predictive Hepatotoxicity at the Intersection of Experimental, in Silico, and Artificial Intelligence Technologies.
    Fraser K; Bruckner DM; Dordick JS
    Chem Res Toxicol; 2018 Jun; 31(6):412-430. PubMed ID: 29722533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of new technologies to characterization and prediction of adverse effects.
    Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
    Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An expert system approach to the assessment of hepatotoxic potential.
    Marchant CA; Fisk L; Note RR; Patel ML; Suárez D
    Chem Biodivers; 2009 Nov; 6(11):2107-14. PubMed ID: 19937847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico models for drug-induced liver injury--current status.
    Przybylak KR; Cronin MT
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):201-17. PubMed ID: 22248266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.